Thrombopoietic activity of human interleukin-6

FEBS Lett. 1990 Jan 29;260(2):176-8. doi: 10.1016/0014-5793(90)80097-3.

Abstract

Thrombopoietin (TPO), a regulatory factor in platelet production, was purified from the conditioned medium of TNK-01 cells cultured in the presence of human interleukin-1. The N-terminal sequence of purified TPO was determined to be VPPGEDSKDVAAPHRQPLT, identical to that of the N-terminal region of human interleukin-6 (IL-6). Two forms of TPO with molecular masses of 24 and 27 kDa were identified as IL-6 by Western analysis using an anti-IL-6 antibody. Commercial recombinant human IL-6 produced in Escherichia coli, stimulated megakaryocyte colony formation in the presence of mouse interleukin-3 and increased the number of peripheral platelets in mice in a dose-dependent manner. From these results, it is concluded that human IL-6 has thrombopoietic activity.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Sequence
  • Amino Acids / analysis
  • Animals
  • Bone Marrow / drug effects
  • Colony-Forming Units Assay
  • Electrophoresis / methods
  • Glycoproteins / isolation & purification*
  • Humans
  • Interleukin-6 / analysis*
  • Interleukin-6 / pharmacology
  • Liposarcoma / metabolism
  • Mice
  • Platelet Count / drug effects*
  • Recombinant Proteins / analysis
  • Thrombopoietin / analysis
  • Thrombopoietin / isolation & purification*
  • Thrombopoietin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Amino Acids
  • Glycoproteins
  • Interleukin-6
  • Recombinant Proteins
  • Thrombopoietin